Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates. (2021)

First Author: Stamatis C
Attributed to:  FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/biot.202000238

PubMed Identifier: 33231912

Publication URI: http://europepmc.org/abstract/MED/33231912

Type: Journal Article/Review

Volume: 16

Parent Publication: Biotechnology journal

Issue: 4

ISSN: 1860-6768